For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.
Scope of the Report:
This report focuses on the Thebaine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Currently, because of the special properties of thebaine, subject to strict control in most countries, so the market production control by the country's policy.
Thebaine production industry is a highly profitable industry. In the United States and other regions, more and more enterprises begin to apply to enter this field, but the current situation, the market is still controlled by the Mallinckrodt Pharmaceuticals and Noramco.
But as the downstream drugs market gradually matures, the next few years, thebaine and his relevant market will gradually popular, so the next few years, thebaine have a certain degree of price rise, but the rate should be minimal
The worldwide market for Thebaine is expected to grow at a CAGR of roughly 1.1% over the next five years, will reach 1240 million US$ in 2023, from 1160 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Mallinckrodt Pharmaceuticals
- Tasmanian Alkaloids
- Taj Pharmaceuticals
- API Labs
- Faran Shimi Pharmaceuticals
- Gansu Alkaloids
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Food Grade
- Pharmaceutical Grade
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Thebaine market.
Chapter 1, to describe Thebaine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Thebaine, with sales, revenue, and price of Thebaine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Thebaine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Thebaine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Thebaine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source